E-cigarettes can significantly alter a body’s response to viruses, study finds

Credit: Unsplash/CC0 Public Domain

Researchers at UNC-Chapel Hill have found that people who use e-cigarettes have significantly altered immune responses to influenza viruses, a worrying discovery as flu season approaches and COVID-19 surges across the U.S.

E-cigarettes have boomed in popularity across the U.S. in the past decade, even as the use of traditional cigarettes declined. The rise has been especially pronounced among the youth population.

Because of that, researchers have been focusing more attention on the potential health risks of e-cigarettes. This is especially true with a respiratory-related pandemic raging across the global.

“There’s been a lot of questions in the field as to whether and cigarette use is beneficial or damaging or problematic in terms of COVID, and we really haven’t had a good answer,” Meghan Rebuli, an assistant professor in the UNC Department of Pediatrics, said in an interview.

But when compared to non-users, people who vaped e-cigarettes showed more changes in the immune genes in their respiratory cells that fight off viruses. They also showed a suppressed level of antibodies.

In many of the study’s participants, this change was even more pronounced among e-cigarette users than among smokers.

The findings, which compared e-cigarette users to cigarette smokers and non-smokers, were published in the medical journal American Journal of Respiratory Cell and Molecular Biology.

And while the study focused on a flu model, the findings suggest that e-cigarette users are likely more susceptible to respiratory viruses like COVID-19 than non-smokers, Rebuli said.

“We don’t want to see any suppression of genes, proteins and antibodies involved in an ,” she said. But that is exactly what they saw among those smoking both traditional and electronic cigarettes.

“E-cigarette use is not safe or safer than cigarettes, and that is a really important take-home message,” Rebuli said. “You probably shouldn’t be inhaling any kind of tobacco-related products; it all impairs your immune response to the viruses.”

Rebuli added that if you do smoke or vape, “You need to be hyper vigilant about using PPE and protecting yourself from COVID and from respiratory viral infections, because you may be more susceptible to adverse responses to these viruses.”

UNC’s study compared non-smokers, cigarette smokers and e-cigarette users between the ages of 18 and 40. The researchers inoculated participants with a live attenuated influenza virus, a modeled flu infection that allows researchers to safely examine immune responses in subjects.

After comparing the nasal fluid and other biomarkers of the patients, the researchers did not find that the viral load, or the amount of the virus in a person, differed among the three groups in the study.

But they did find a decreased expression of critical for defense against a virus as well as the genes that help train the body to prevent reinfection.

“This is not good,” Ilona Jaspers, the director of the UNC Center for Environmental Medicine, Asthma, and Lung Biology, said in a statement.

“We want to see (these) levels increase during infection,” she added. “It’s the body’s natural way to defend against an invader. Here we saw that both smoking and e-cigarette use hampers (immune gene) levels.”

Rebuli said this could be worrisome news for vaccine effectiveness among this population as well.

These genes are also important for helping the body’s immune system recognize a virus that it has encountered before.

“Your body can recognize the and create kind of an immune memory … which prevents you from subsequent infection,” she said. “That is how a vaccine works.”

“The question here,” she added, “is if this is a 90% effective vaccine, is it going to be similarly effective in e-cig users, or are they going to have trouble generating that immune memory?”

That is still unclear at this time, Rebuli said. Further studies are needed that look at COVID-19 specifically.

The study was funded by the National Institutes of Health, the U.S. Food and Drug Administration, and a Leon and Bertha Golberg Postdoctoral Fellowship.

Are e-cigarette users at greater risk of poor immune response to flu, COVID-19?

©2020 The News & Observer (Raleigh, N.C.)
Distributed by Tribune Content Agency, LLC

E-cigarettes can significantly alter a body’s response to viruses, study finds (2020, November 16)
retrieved 16 November 2020
from https://medicalxpress.com/news/2020-11-e-cigarettes-significantly-body-response-viruses.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.

Source link

Health News

Aromatherapy spray linked to US deaths faces recall

This undated photo provided by Walmart and the U.S. Centers for Disease Control and Prevention shows a bottle of Better Homes & Gardens aromatherapy lavender & chamomile essential oil and semiprecious stone-infused room spray. The Consumer Product Safety Commission and Walmart issued a recall Friday, Oct. 22. 2021, for 3,900 bottles of the spray. Credit: Walmart/CDC […]

Read More
Health News

mRNA vaccine more effective booster to ChAdOx1 nCoV-19

(HealthDay)—Use of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination is more effective than homologous ChAdOx1 nCoV-19/ChAdOx1 nCoV-19 prime-boost vaccination, according to a study published online Oct. 17 in The Lancet Regional Health: Europe. Peter Nordström, M.D., Ph.D., from Umeå University in Sweden, and colleagues examined the effectiveness of heterologous prime-boost COVID-19 vaccination among individuals in […]

Read More
Health News

Moving monoclonal antibody treatments for COVID from hospital to home

(HealthDay)—Antibody infusions help keep high-risk COVID-19 patients out of the hospital, but getting the therapy can be a challenge. One U.S. health system has found a creative way to address the problem: home infusions administered by paramedics. They delivered antibody infusions to 144 COVID-19 patients in their homes over three months earlier this year. Most—about […]

Read More